Monday, October 20, 2014

Hot Life Sciences Stocks To Invest In Right Now

Any company that creates products and relies on other companies to use and distribute them will inevitably forge strong relationships with its customers. It's an important thing to look into when investing, yet easy to overlook. Investors should know whether customers are reliable, which are leaned on the most, and if the company they own is too dependent on any customer (or a select few). Bioprocessing product company Repligen (NASDAQ: RGEN  ) may make consumables that are the lifeline of the biotech industry, but its customer relationships are absolutely critical for smooth operations. Let's look at how the company interacts with the Life Sciences division of General Electric (NYSE: GE  ) , EMD Millipore from Merck (NYSE: MRK  ) , and Sigma-Aldrich (NASDAQ: SIAL  ) -- the three most important customers.

Source: Repligen Stephens Fall Investment Conference.

Hot China Stocks To Buy For 2015: Electro Scientific Industries Inc (ESIO)

Electro Scientific Industries, Inc. (ESI) incorporated on April 19, 1949, is a supplier of laser-based manufacturing solutions for the microtechnology industry. The Company operates high-technology manufacturing equipment, which consists of products that are organized in three groups: interconnect & microfabrication, semiconductor and components. The Company�� laser systems enable precise structuring of micron to submicron features in components and devices which are used in a wide variety of end products in the consumer electronics, computer, semiconductor, communications and other markets. Its laser microfabrication systems allow microelectronics, semiconductor, and other microtechnology manufacturers to physically alter select device features during high-volume production. In June 2012, it acquired Eolite Systems.

The Company�� laser-based systems improve production yields or enable improved performance for flexible and rigid high density interconnect printed circuit boards, semiconductor devices, light emitting diodes (LEDs), advanced semiconductor packaging, touch-panel glass, flat panel liquid crystal displays (LCDs) and other high value components. Additionally, it produces high-capacity test and inspection equipment that is critical to control process during the production of multilayer ceramic capacitors (MLCCs). Its equipment ensures that each component meets the electrical and physical tolerances required to perform properly. Lastly, it produces systems that use photonic technology to perform precision inspection for control and defect identification. The Company�� Interconnect & Microfabrication Group products address an expanding number of applications and materials on a broad set of substrates, including panels, continuous-feed reels, and discrete three dimensional components or devices.

Interconnect Via Drilling

For electrical interconnect applications, The Company�� laser via micro fabrication systems target applications that require the ! highest accuracy and smallest via (hole) dimensions to create electrical connections between layers in flexible circuits, high-density circuit boards and IC packages. The Company�� microvia drilling technology addresses the rapidly changing applications in IC packages, multichip modules and HDI circuit boards. Its ultraviolet (UV) laser processing systems employ technology in lasers, optics and motion control.

Advanced Microfabrication

The Company offers several platforms that enable customers to perform precision drilling, scribing, cutting, etching, routing or marking on many different types of materials and devices including glass, metal, plastic, paint and ceramics. It also offer laser ablation systems that ablate material for identification and analysis applications, including forensics, mineral analysis and research.

Semiconductor Group (SG)

The Company�� Semiconductor Group products address multiple applications that utilize laser energy to process materials on wafer-based substrates. This includes traditional silicon wafers, LEDs wafers, and new ultrathin silicon wafers used in the three-dimensional (3D) packaging applications. Semiconductor Memory Yield Improvement Systems includes semiconductor memory yield improvement products are designed to cost-effectively enable post-repair yield improvements in the manufacturing of dynamic random access memory (DRAM) memory devices.

3D Semiconductor Wafer Processing

The 3D chip packaging technologies is driving the need for silicon wafers to become thinner in order to allow for stacking of wafers within the same packaging geometry. As wafers become thinner, they become more challenging to cut into discrete chips using traditional mechanical saws. The Company�� model 9900 uses a laser to dice ultra-thin silicon wafers, those with a thickness of 50 microns or below, and to singulate interposers. In addition, this platform can be used to scribe next generation thin film ! materials! that lend themselves to laser processing.

LED Wafer Scribing

The Company�� AccuScribe line of sapphire wafer scribing systems is a key component in the manufacture of LEDs. During production, LEDs are created on a thin wafer of synthetic sapphire crystal that must be broken into individual units at the end of the process. The brittle nature of the sapphire wafer requires that it be carefully cut in order to prevent unwanted fractures, yield losses, and lower light output when the wafer is broken apart into discrete LEDs. The AccuScribe systems use a laser to scribe the wafer with a precise groove between individual LEDs. When mechanical force is applied to the wafer, it fractures along these grooves and allows the wafer to be split apart into discrete LEDs. These systems are capable of scribing both standard and high brightness designs for general illumination applications. In addition, this platform can be used to address singulation of various LED packaging materials.

LCD Repair

The Comapny's laser LCD repair systems are critical to improving yields in the manufacture of flat panel displays. During production, individual pixels of a display may develop electrical defects that result in no light emission or the emission of only a steady white light. To correct these defects, flat panel display producers employ a laser repair process to isolate the electrical defects during production by cutting the inputs to the pixel. Its laser systems are primarily sold to the manufacturers of LCD repair tools as a key component of their products.

Semiconductor Systems

The products include industry wafer marking equipment, wafer and circuit trim tools, and LCD repair tools. Wafer marking equipment is used for serialization and wafer identification by both manufacturers of semiconductor wafers and within semiconductor fabs. Wafer and circuit trim tools are laser systems that adjust the electrical performance of semiconductor devic! es or hyb! rid circuits by removing a precise amount of material from one or more circuit components.

Components Group (CG)

The Company designs and manufactures products that combine high-speed small parts handling technology with real-time control systems to provide automated, cost-effective inspection solutions for manufacturers of MLCC and other passive components such as capacitor arrays, inductors, resistors, varistors and hybrid circuits. These components, produced in quantities of trillions of units per year, process analog, digital and high-frequency signals and are used in all electronic products.

The Company provides several types of products and solutions in this market. Its MLCC test systems employ high-speed handling and positioning techniques to precisely load, test and sort MLCCs based on their electrical energy storage capacity, or capacitance, and their electrical energy leakage, or dissipation factor. Its 35XX series is the productive tester. Its 3510 model enables high speed testing of the industry�� smallest metric 0402 capacitors used primarily in advanced cell phone and tablet designs. It also produces consumable products, such as carrier plates and termination belts, both of which are used to hold MLCCs during the manufacturing and testing process.

The Company competes with Mechanics, Ltd., LPKF Laser & Electronics AG, Mitsubishi Electric Corporation, Orbotech Ltd., InnoLas Systems GmbH, DISCO Corporation, Laser Solutions, Inc., Quantel USA, Inc., Humo Laboratory, Ltd. and HOYA Corporation.

Advisors' Opinion:
  • [By Eric Volkman]

    Electro Scientific Industries (NASDAQ: ESIO  ) has a new division under its corporate wing. The company has inked a definitive agreement to purchase the semiconductor systems unit of GSI Group (NASDAQ: GSIG  ) . The terms of the deal were not disclosed.

  • [By Evan Niu, CFA]

    What: Shares of Electro Scientific (NASDAQ: ESIO  ) popped briefly today, up by 11% at the high, after the company reported earnings.

    So what: Revenue in the fiscal fourth quarter totaled $39.6 million, which translated into a non-GAAP net loss of $1 million, or $0.03 per share. Both figures came out better than expected, as consensus estimates were calling for $38.1 million in revenue and an adjusted loss of $0.07 per share.

Hot Life Sciences Stocks To Invest In Right Now: Plum Creek Timber Company Inc.(PCL)

Plum Creek Timber Company, Inc. is a publicly owned real estate investment trust (REIT). The trust owns and manages timberlands in the United States. Its products include lumber products, plywood, medium density fiberboard, and related by-products, such as wood chips. The trust also focuses on mineral extraction and natural gas production, communication, and transportation. Plum Creek Timber Company was founded in 1989 and is based in Seattle, Washington.

Advisors' Opinion:
  • [By Ben Levisohn]

    Among stocks in the S&P 500, CBRE Group (CBG) has dropped 5.5% to $23.05 after it reported a profit of 30 cents a share, missing forecasts for 33 cents. Aflac (AFL), meanwhile, has fallen 3% to $65 after it reported a profit of $1.47, missing estimates for $1.48 on weakness in Japan. Plum Creek Timber (PCL) has dropped 1.3% to $45.76 after announcing that it would sell 12.1 million shares of stock at $45.

  • [By Saibus Research]

    WY and the majority of the timber, forest and paper products companies have a track record of unimpressive returns on capital, cyclical revenue and profit trends, heavy use of capital expenditures, and significant environmental regulation. We also think that WY's conversion to a REIT was a mistake. Morningstar Investment Research's Timber, Forest and Paper Products analyst Dan Rohr said it best when he rated WY and its Timber REIT peers Rayonier (RYN), Potlatch (PCH) and Plum Creek (PCL) as not possessing any economic moat. That probably explains why we only have an ancillary exposure to this industry for our proprietary portfolio based on our holdings in Brookfield Infrastructure (BIP) and Cintas (CTAS). Brookfield's Timber segment only accounts for 5% of its Fund Flows from operations and Cintas's document management business is suffering from reduced prices on recycled paper. At least Cintas Document Management only accounts for 8% of Cintas's revenue.

  • [By Rich Smith]

    Someone's yelling "timber!" at Plum Creek
    Forest manager and forestry products seller Plum Creek Timber (NYSE: PCL  ) beat analyst estimates (with a stick, of course) Monday. Earnings for the first fiscal quarter came in at $0.35 per share, or close to 10% better than expected. Revenue of $340 million also topped estimates.

  • [By Matt DiLallo]

    For perspective, Weyerhaeuser owns almost as many total acres in the Pacific Northwest as Rayonier (NYSE: RYN  ) has in its entire portfolio, and well above the nearly 390,000 acres it has in the Pacific Northwest. Weyerhaeuser is also well above No. 2 timberland owner Plum Creek (NYSE: PCL  ) which holds just 471,000 acres in the Pacific Northwest. These newly acquired acres really puts Weyerhaeuser in a league of its own when it comes to having assets in the strategic Pacific Northwest.

Hot Life Sciences Stocks To Invest In Right Now: Singapore Airlines Ltd (SINGY)

Singapore Airlines Limited is a passenger air transportation company. The Company, together with its subsidiaries, is engaged in passenger and cargo air transportation, engineering services, training of pilots, air charters and tour wholesaling and related activities. The Company consists of 101 aircrafts. The Company operates in four segments: airline operations, cargo operations, engineering services and others. The Company's subsidiaries are SIA Engineering Company Limited (SIAEC), SIA Cargo and SilkAir (Singapore) Private Limited (SilkAir). Effective December 24, 2013, Singapore Airlines Ltd, a unit of Temasek Holdings (Pte) Ltd, raised its interest to 40.004% from 32.67% by acquiring a 7.334% interest in Tiger Airways Holdings Ltd from Dahlia Investments Ptye Ltd and Aranda Investments Pte Ltd. Advisors' Opinion:
  • [By Bruce Kennedy]

    Business travel columnist Joe Brancatelli reports the world's longest non-stop commercial route, the Singapore Airlines (OTC: SINGY) 18-hour, business class-only flight between Newark, N.J. and Singapore, will end on Saturday. The airline also retired the world's second-longest non-stop flight, Los Angeles-to-Singapore, last month.

Hot Life Sciences Stocks To Invest In Right Now: China Biologic Products Inc.(CBPO)

China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People?s Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection that is used in the treatment of various original and sec ondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides Human Rabies Immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; Human Tetanus Immunoglobulin for the prevention and therapy of tetanus; and Placenta Polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company?s products under development comprise Human Prothrombin Complex Concentrate; Human Coagulation Factor VIII; Human Hepatitis B Immunoglobulin (PH4) for Intravenous Injection; Human Fibrinogen; Varicella Hyperimmune Globulins; and Human Immunoglobulin for Intravenous Injection. The company is based in Beijing, the People's Republic of China.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.

Hot Life Sciences Stocks To Invest In Right Now: Dendreon Corporation(DNDN)

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy and small molecule product candidates to treat various cancers. Its product candidates comprise Provenge (sipuleucel-T), an active cellular immunotherapy for the treatment of metastatic, castrate-resistant prostate cancer; DN24-02, an investigational active immunotherapy for the treatment of patients with bladder, breast, ovarian, and other solid tumors expressing HER2/neu; and TRPM8, a small molecule agonist to transient receptor potential ion channel, for multiple cancers. The company also has a range of products in preclinical studies, which include Carcinoembryonic antigen for the treatment of lung, colon, and breast cancer; and Carbonic AnhydraseIX for the treatment of kidney cancer. Dendreon Corporation was founded in 1992 and is headquartered in S eattle, Washington.

Advisors' Opinion:
  • [By Brian Orelli]

    "We believe that the fourth quarter may be our strongest quarter of the year," said John Johnson, Dendreon's (NASDAQ: DNDN  ) �chairman, CEO, and president.

Hot Life Sciences Stocks To Invest In Right Now: Omnicare Inc (OCR)

Omnicare, Inc. (Omnicare) is a healthcare services company. The Company operates in two primary businesses: Long-Term Care Group (LTC) and Specialty Care Group (SCG). Through LTC, Omnicare provides pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. SCG provides commercialization services for the biopharmaceutical industry in addition to end-of-life pharmaceutical care management for hospice care agencies. At December 31, 2011, LTC provided its pharmacy services in 47 states in the United States, the District of Columbia and in Canada. In September 2012, Five Star Quality Care, Inc. sold its pharmacy business to Omnicare.

Long-Term Care Group

Omnicare operates the institutional pharmacy business in North America. LTC's customers consist of skilled nursing facilities (SNFs), assisted living facilities (ALFs), independent living communities, hospitals, correctional facilities, and other healthcare service providers. LTC consisted of approximately 83% of the Company�� total net sales during the year ended December 31, 2011 and dispensed approximately 115.1 million prescriptions. The Company provides pharmacy consulting, including monthly patient drug therapy evaluations, assist in compliance with state and federal regulations and provide clinical and health management programs (utilizing outcomes-based algorithm technology). LTC also provides a range of technology solutions based on its Omniview Web-based platform.

LTC also provides a range of other products and services, including intravenous medications and nutrition products (infusion therapy products and services), respiratory therapy services, medical supplies and equipment (including billing the Medicare Part B program for eligible patients) and clinical care planning. It also provides pharmaceutical case management services for retirees, employees and dependents. The Company purchases, repackages and dispenses presc! ription and non-prescription medication in accordance with physician orders and deliver such prescriptions to long-term care facilities for administration to individual residents (by the facilities��nursing staff for SNFs).

The Company services long-term care facilities typically within a radius of approximately 150 miles of its pharmacy locations and maintain an around-the-clock, seven-day per week, on-call pharmacist service for emergency dispensing and delivery, and for consultation with the facility's staff or attending physician. The Company utilizes a unit-of-use drug distribution system. This means that its prescriptions are packaged for dispensing in individual doses. The Company�� range of technologies allow Web-based access to electronic medical records, automated pharmacy billing, online medication refills and returns processing, census tracking, pre-admission medication assessment and access to the Omnicare Guidelines.

Specialty Care Group

SCG serves the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its services are based on five platforms: brand support services, third party logistics, patient assistance programs, specialty pharmacy and disease management for end-of-life care. In the Company�� specialty pharmacy platform, it provides dispensing of specialized pharmaceuticals. These specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology and growth hormones. In its end-of-life care platform, Omnicare provides hospice care pharmaceutical management. SCG accounted for approximately 17% of the Company�� total net sales during 2011.

Omnicare competes with PharMerica Corporation.

Advisors' Opinion:
  • [By Benjamin Shepherd]

    The American long-term care industry has been growing rapidly and will continue doing so for years to come. According to a study from the US Department of Health and Human Services, more than 70 percent of Americans over the age of 65 will need long-term care services at some point in their lives. Anyone over the age of 65 has a 40 percent chance of entering a nursing home and about 20 percent of them will remain there for at least five years.

    The size of the 65 and older population jumped by more than 15 percent between 2000 and 2010, compared to just 9.7 percent growth in the population as a whole. That group now makes up about 13 percent of the total population and is forecast to account for more than 16 percent by the end of this decade and 20.2 percent by 2050.

    Those trends have spurred huge runs for real estate investment trusts (REIT) that operate assisted-living facilities, rehabilitation centers and nursing homes across the country. While the senior living REITs have been an extremely profitable play on America�� graying population, their tide is ebbing with the prospect of rising interest rates creating fears that their profitability will be dinged. That creates opportunities for value investors focused on long-term returns, but it means short-term volatility.

    In this context, one compelling investment now is Omnicare (NYSE: OCR), a company that provides pharmacy services to long-term care and other medical facilities. Omnicare receives prescription orders from physicians at facilities, reviews them for effectiveness and any potential interactions with other drugs the patient is receiving and then prepares the drugs in specialized individual packages for easy administration.

    Omnicare has consultant pharmacists who can regularly review patient charts for potential interactions and duplications or to recommend alternative drugs or formulations that can increase the effectiveness of a patient�� medications, while also potent

Hot Life Sciences Stocks To Invest In Right Now: U.S. Bancorp(USB)

U.S. Bancorp, a financial services holding company, provides various banking and financial services in the United States. It generates various deposit products, including checking accounts, savings accounts, money market savings, and time certificates of deposit accounts. The company originates a portfolio of loans comprising commercial loans and lease financing; commercial real estate; residential mortgage; and retail loans consisting of credit cards, retail leasing, home equity and second mortgages, and other retail loans. It also offers wholesale lending, equipment finance, small-ticket leasing, depository, treasury management, capital markets, foreign exchange, and international trade services to middle market, large corporate, commercial real estate, and public sector clients. In addition, U.S. Bancorp provides telebanking and automated teller machine (ATM) services, as well as cash management services. The company, through other subsidiaries, provides trust, private banking, financial advisory, investment management, retail brokerage services, insurance, and custody and fund services; and payment services, including consumer and business credit cards, stored-value cards, debit cards, corporate and purchasing card services, consumer lines of credit, and merchant processing. U.S. Bancorp primarily serves individuals, estates, foundations, business corporations, and charitable organizations. It operates a network of approximately 3,031 banking offices and 5,310 ATMs. The company was founded in 1863 and is headquartered in Minneapolis, Minnesota.

Advisors' Opinion:
  • [By Dan Caplinger]

    5. Minnesota
    Among Minnesotans, 32.7% claimed a charitable deduction on their tax returns. With median contributions of $2,213 per taxpayer, Minnesota gave a total of $2.6 billion. Corporate giving in Minnesota is also a high priority, with foundations associated with 3M and US Bancorp (NYSE: USB  ) among many with annual giving amounts of $10 million or more. US Bancorp recently started accepting donations at its ATMs for Oklahoma-directed efforts of the American Red Cross.

  • [By John Maxfield]

    And if you're an investor, it'd behoove you to follow these rates as well. This is particularly true for the nation's largest mortgage originators, among them Wells Fargo (NYSE: WFC  ) , JPMorgan Chase (NYSE: JPM  ) , Bank of America (NYSE: BAC  ) , and US Bancorp (NYSE: USB  ) .

  • [By Jon C. Ogg]

    U.S. Bancorp (NYSE: USB) is nowhere near as large of a stake as Wells Fargo, but Warren Buffett keeps growing this stake as well. Its higher-end customer has to be attractive to Buffett. The stake grew to 79.11 million shares, versus a prior stake of 78.277 million shares. It had also been raised from 61.458 million shares prior to that. This stock was not reacting positively and was actually down $0.10 at $38.18 in mid-Friday trading. Still, its shares did briefly hit a new high of $38.39 on Friday. The consensus price target was $39.97 on last look, and new investors are getting a 2.4% yield here, even at these high prices.

No comments:

Post a Comment